These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 1501741

  • 1. Two cases in whom pyrazinamide does not inhibit the uricosuric action of benzbromarone.
    Yamamoto T, Moriwaki Y, Takahashi S, Suda M, Agbedana EO, Higashino K.
    Nephron; 1992; 61(4):432-4. PubMed ID: 1501741
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The pharmacology of hypouricemic effect of benzbromarone.
    Sinclair DS, Fox IH.
    J Rheumatol; 1975 Dec; 2(4):437-45. PubMed ID: 1206675
    [Abstract] [Full Text] [Related]

  • 6. Pharmacologic evaluation of the renal handling of uric acid and oxypurines.
    Hiroshige K, Takasugi M, Yuu K, Kuroiwa A.
    Nihon Jinzo Gakkai Shi; 1994 Nov; 36(11):1268-75. PubMed ID: 7853759
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hereditary renal hypouricemia in children.
    Takeda E, Kuroda Y, Ito M, Toshima K, Watanabe T, Ito M, Naito E, Yokota I, Hwang TJ, Miyao M.
    J Pediatr; 1985 Jul; 107(1):71-4. PubMed ID: 4009341
    [Abstract] [Full Text] [Related]

  • 9. Isolated defect in postsecretory reabsorption of uric acid.
    Sorensen LB, Levinson DJ.
    Ann Rheum Dis; 1980 Apr; 39(2):180-3. PubMed ID: 7387223
    [Abstract] [Full Text] [Related]

  • 10. Analysis of uric acid transport in renal tubules using benzbromarone and pyrazinamide.
    Moriwaki Y, Yamamoto T, Takahashi S, Hada T, Higashino K.
    Int J Clin Pharmacol Ther Toxicol; 1990 Feb; 28(2):84-8. PubMed ID: 2307550
    [Abstract] [Full Text] [Related]

  • 11. Renal hypouricemia due to enhanced tubular secretion of urate associated with urolithiasis: successful treatment of urolithiasis by alkalization of urine K+, Na(+)-citrate.
    Hisatome I, Tanaka Y, Kotake H, Kosaka H, Hirata N, Fujimoto Y, Yoshida A, Shigemasa C, Mashiba H, Sato R.
    Nephron; 1993 Feb; 65(4):578-82. PubMed ID: 8302413
    [Abstract] [Full Text] [Related]

  • 12. Hypouricemia due to renal urate wasting. Two types of tubular transport defect.
    Tofuku Y, Kuroda M, Takeda R.
    Nephron; 1982 Feb; 30(1):39-44. PubMed ID: 7088231
    [Abstract] [Full Text] [Related]

  • 13. The pharmacology of the hypouricemic effect of benzbromarone.
    Fox IH, Sinclair DS.
    Adv Exp Med Biol; 1977 Feb; 76B():328-33. PubMed ID: 855759
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Benzbromarone: a review of its pharmacological properties and therapeutic use in gout and hyperuricaemia.
    Heel RC, Brogden RN, Speight TM, Avery GS.
    Drugs; 1977 Nov; 14(5):349-66. PubMed ID: 338280
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Uric acid transport in fanconi syndrome with marked renal hypouricemia: analysis using pyrazinamide and benzbromarone.
    Moriwaki Y, Yamamoto T, Takahashi S, Hiroishi K, Yamakita J, Nasako Y, Naito Y, Higashino K.
    Nephron; 1996 Nov; 74(2):452-3. PubMed ID: 8893184
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.